Prestige Consumer Healthcare (PBH) stock is soaring 5.31% in pre-market trading on Thursday following the release of its impressive fourth-quarter results and fiscal 2025 performance. The company reported better-than-expected earnings and revenue, demonstrating resilience in a challenging market environment.

For the fourth quarter, Prestige Consumer Healthcare posted adjusted earnings per share of $1.32, surpassing analysts' expectations of $1.30 and marking a significant increase from $1.02 in the same period last year. Revenue for the quarter reached $296.518 million, exceeding the estimated $289.4 million and showing growth from $277 million in the previous year. The company's gross profit for Q4 stood at $170.01 million, reflecting strong operational efficiency.

Looking ahead, Prestige Consumer Healthcare provided an optimistic outlook for fiscal 2026, projecting diluted earnings per share between $4.70 and $4.82 on revenue ranging from $1.14 billion to $1.16 billion. The company also anticipates organic growth of 1-2% for the fiscal year. However, it noted a potential $15 million headwind related to inflationary impacts from enacted tariffs, demonstrating its proactive approach to addressing market challenges.